Literature DB >> 25193995

Disruption of tumor suppressor gene Hint1 leads to remodeling of the lipid metabolic phenotype of mouse liver.

Diren Beyoğlu1, Kristopher W Krausz2, Juliette Martin1, Olivier Maurhofer1, Juliane Dorow3, Uta Ceglarek3, Frank J Gonzalez2, Jean-François Dufour1, Jeffrey R Idle4.   

Abstract

A lipidomic and metabolomic investigation of serum and liver from mice was performed to gain insight into the tumor suppressor gene Hint1. A major reprogramming of lipid homeostasis was found in both serum and liver of Hint1-null (Hint(-/-)) mice, with significant changes in the levels of many lipid molecules, as compared with gender-, age-, and strain-matched WT mice. In the Hint1(-/-) mice, serum total and esterified cholesterol were reduced 2.5-fold, and lysophosphatidylcholines (LPCs) and lysophosphatidic acids were 10-fold elevated in serum, with a corresponding fall in phosphatidylcholines (PCs). In the liver, MUFAs and PUFAs, including arachidonic acid (AA) and its metabolic precursors, were also raised, as was mRNA encoding enzymes involved in AA de novo synthesis. There was also a significant 50% increase in hepatic macrophages in the Hint1(-/-) mice. Several hepatic ceramides and acylcarnitines were decreased in the livers of Hint1(-/-) mice. The changes in serum LPCs and PCs were neither related to hepatic phospholipase A2 activity nor to mRNAs encoding lysophosphatidylcholine acetyltransferases 1-4. The lipidomic phenotype of the Hint1(-/-) mouse revealed decreased inflammatory eicosanoids with elevated proliferative mediators that, combined with decreased ceramide apoptosis signaling molecules, may contribute to the tumor suppressor activity of Hint1.
Copyright © 2014 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  apoptosis; carcinogenesis; cholesterol; eicosanoids; lipidomics; mass spectrometry; metabolomics; phospholipids; proliferation

Mesh:

Substances:

Year:  2014        PMID: 25193995      PMCID: PMC4617133          DOI: 10.1194/jlr.M050682

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  46 in total

Review 1.  Autotaxin and LPA receptor signaling in cancer.

Authors:  Anna J S Houben; Wouter H Moolenaar
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

2.  Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha.

Authors:  Bo Wang; Shu-Hao Hsu; Wendy Frankel; Kalpana Ghoshal; Samson T Jacob
Journal:  Hepatology       Date:  2012-06-05       Impact factor: 17.425

3.  Ceramide regulation of the tumor suppressor phosphatase PTEN in rafts isolated from neurotumor cell lines.

Authors:  R Goswami; D Singh; G Phillips; J Kilkus; G Dawson
Journal:  J Neurosci Res       Date:  2005-08-15       Impact factor: 4.164

Review 4.  Hepatocarcinogenesis and ceramide/cholesterol metabolism.

Authors:  Albert Morales; Montserrat Mari; Carmen Garcia-Ruiz; Anna Colell; Jose C Fernandez-Checa
Journal:  Anticancer Agents Med Chem       Date:  2012-05       Impact factor: 2.505

Review 5.  Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays.

Authors:  Semjon Willier; Elke Butt; Thomas G P Grunewald
Journal:  Biol Cell       Date:  2013-06-03       Impact factor: 4.458

Review 6.  The metabolomic window into hepatobiliary disease.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  J Hepatol       Date:  2013-05-25       Impact factor: 25.083

Review 7.  Sphingomyelin and its role in cellular signaling.

Authors:  Mahua Chakraborty; Xian-Cheng Jiang
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

8.  Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study .

Authors:  Lydia Giannitrapani; Sabrina Ingrao; Maurizio Soresi; Ada Maria Florena; Emanuele La Spada; Luigi Sandonato; Natale D'Alessandro; Melchiorre Cervello; Giuseppe Montalto
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

9.  Lung Krüppel-like factor (LKLF) is a transcriptional activator of the cytosolic phospholipase A2 alpha promoter.

Authors:  Marilee J Wick; Stacy Blaine; Vicki Van Putten; Milene Saavedra; Raphael A Nemenoff
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

10.  Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axis.

Authors:  D Lu; C Han; T Wu
Journal:  Oncogene       Date:  2011-07-11       Impact factor: 9.867

View more
  3 in total

Review 1.  Axonal neuropathy with neuromyotonia: there is a HINT.

Authors:  Kristien Peeters; Teodora Chamova; Ivailo Tournev; Albena Jordanova
Journal:  Brain       Date:  2017-04-01       Impact factor: 13.501

2.  The plasma lipidome in acute myeloid leukemia at diagnosis in relation to clinical disease features.

Authors:  Thomas Pabst; Linda Kortz; Georg M Fiedler; Uta Ceglarek; Jeffrey R Idle; Diren Beyoğlu
Journal:  BBA Clin       Date:  2017-03-08

3.  Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes.

Authors:  Peter Willeit; Philipp Skroblin; Alexander R Moschen; Xiaoke Yin; Dorothee Kaudewitz; Anna Zampetaki; Temo Barwari; Meredith Whitehead; Cristina M Ramírez; Leigh Goedeke; Noemi Rotllan; Enzo Bonora; Alun D Hughes; Peter Santer; Carlos Fernández-Hernando; Herbert Tilg; Johann Willeit; Stefan Kiechl; Manuel Mayr
Journal:  Diabetes       Date:  2016-11-29       Impact factor: 9.461

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.